α-sheet: The toxic conformer in amyloid diseases?

Accounts of Chemical Research

Volumn 39, Issue 9, 2006, Pages 594-602

  Daggett, Valerie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

AMYLOIDOSIS; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION; REVIEW;

AMYLOID; AMYLOIDOSIS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION;

EID: 33749857843     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar0500719     Document Type: Review

References (72)

1. Westermark, P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 2006, 272, 5942-5949.
2. Blake, C.; Serpell, L. Synchotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 1996, 4, 989-998.
3. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002, 297, 353-356.
4. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J. S.; Taddei, N.; Ramponi, G.; Dobson, C. M.; Stefani, M. Nature 2002, 416, 507-511.
5. Silveira, J.; Raymond, G. J.; Hughson, A. G.; Race, R. E.; Sim, V. L.; Hayes, S. F.; Caughey, B. The most infectious prion protein particles. Nature 2005, 437, 257-261.
6. Bodner, R. A.; Outeiro, T. F.; Altmann, S.; Maxwell, M. M.; Cho, S. H.; Hyman, B. T.; McLean, P. J.; Young, A. B.; Housman, D. E.; Kazantsev, A. G. Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 4246-4251.
7. Kayed, R.; Head, E.; Thompson J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300, 486-489.
8. Glabe, C. G.; Kayed, R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 2006, 66, S74-S78.
9. Lundmark, K.; Westermark, G. T.; Nystrom, S.; Murphy, C. L.; Solomon, A.; Westermark, P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 6979-6984.
10. Saraiva, M. J. M. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum. Mutat. 2001, 17, 493-503.
11. Inoue, S.; Kuroiwa, M.; Ohashi, K.; Hara, M.; Kisilevsky, R. Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils. Kidney Int. 1997, 52, 1543-1549.
12. Pepys, M. B.; Hawkins, P. N.; Booth, D. R.; Vigushin, D. M.; Tennent, G. A.; Soutar, A. K.; Totty, N.; Nguyen, O.; Blake, C. C. F.; Terry, C. J.; Feest, T. G.; Zalin, A. M.; Hsuan, J. J. Nature 1993, 362, 553-557.
13. Prusiner, S. B. Prions Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 13363-13383.
14. Armen, R. S.; DeMarco, M. L.; Alonso, D. O. V.; Daggett, V. Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11622-11627.
15. Armen, R. S.; Alonso, D. O. V.; Daggett, V. Anatomy of an amyloidogenic intermediate: Conversion of β-sheet to α-pleated sheet structure in transthyretin at acidic pH. Structure 2004, 12, 1847-1863.
16. Armen, R. S.; Daggett, V. Characterization of two distinct β2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology. Biochemistry 2005, 44, 16098-16107.
17. Armen, R. S.; Bernard, B. M.; Day, R.; Alonso, D. O. V.; Daggett, V. Characterization of a possible amyloidogenic precursor in glutamine repeat neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 13433-13438.
18. Laskowski, R. A.; Macarthur, M. W.; Moss, D. S.; Thornton, J. M. Procheck - a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-291.
19. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. H.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
20. 10, and π-helix in Helix → Coil Transitions. Protein Sci. 2003, 12, 1145-1157.
21. Daggett, V.; Kollman, P. A.; Kuntz, I. D. Molecular Dynamics Simulations of Small Peptides: Dependence on Dielectric Model and pH. Biopolymers 1991, 31, 285-304.
22. Yang, M.; Lei, M.; Yordanov, B.; Huo, S. Peptide plane can flip in two opposite directions: Implication in amyloid formation of transthyretin, J. Phys. Chem. B 2006, 110, 5829-5833.
23. Yang, M.; Lei, M.; Bruschweiler, R.; Huo, S. Initial conformational changes of human transthyretin under partially denaturing conditions. Biophys. J. 2005, 89, 433-443.
24. Pauling, L.; Corey, R. B. The pleated sheet, a new layer configuration of polypeptide chains. Proc. Natl. Acad. Sci. U.S.A. 1951, 37, 251-256.
25. Pauling, L.; Corey, R. B. Configurations of polypeptide chains with favored orientations around single bonds: Two new pleated sheets. Proc. Nat. Acad. Sci. U.S.A. 1951, 37, 729-740.
26. Astbury, W. T. Some problems in the X-ray analysis of the structure of animal hairs and other protein fibres. Trans. Faraday Soc. 1933, 29, 193-205.
27. Pauling, L.; Corey, R. B. The structure of feather rachis keratin. Proc. Natl. Acad. Sci. U.S.A. 1951, 37, 256-261.
28. Makin, O. S.; Serpell, L. C. Structures for amyloid fibrils. FEBS J. 2005, 272, 5950-5961.
29. Jimenez, J. L.; Guijarro, J. L.; Orlova, E.; Zurdo, J.; Dobson, C. M.; Sunde, M.; Saibil, H. R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 1999, 18, 815-821.
30. Jimenez, J. L.; Nettleton, E. J.; Bouchard, M.; Robinson, C. V.; Dobson, C. M.; Saibil, H. R. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 9196-9201.
31. Hesselink, F. T.; Scheraga, H. A. Laser raman spectroscopy of polypeptides. II. Spectra of random poly(hydroxybutylglutamine-co-glycine) in the solid state. Macromolecules 1972, 5, 455.
32. DeSantis, P.; Morosetti, S.; Rizzo, R. Conformational analysis of regular enantiomeric sequences. Macromolecules 1974, 7, 52-58.
33. Heitz, F.; Detriche, G.; Vovelle, F.; Spach, G. Sheet structures in alternating poly(D,L-peptides). Macromolecules 1981, 14, 47-50.
34. Di Blasio, B.; Saviano, M.; Fattorusso, R.; Lombardi, A.; Pedone, C.; Valle, V.; Lorenzi, G. P. A crystal structure with features of an antiparallel α-pleated sheet. Biopolymers 1994, 34, 1463-1468.
35. αα-diphenylglycine: Folded vs extended structures in DΦG-containing tripeptides. J. Pept. Sci. 1998, 4, 21-32.
36. De Simone, G.; Lombari, A.; Galdiero, S.; Nastri, F.; Di Costanzo, L.; Gohda, S.; Yamada, T.; Pavone, V. The crystal structure of a Dcp-containing peptide. Biopolymers 2000, 53, 182-188.
37. Vaney, M. C.; Broutin, I.; Retailleau, P.; Douangamath, A.; Lafont, S.; Hamiaux, C.; Prange, T.; Ducruix, A.; Ries-Kautt, M. Structural effects of monovalent anions on polymorphic lysozyme crystals. Acta Crystallogr., Sect. D 2001, 57, 929-940.
38. Nagendra, H. G.; Sukumar, N.; Vijayan, M. Role of water in plasticity, stability, and action of proteins: the crystal structures of lysozyme at very low levels of hydration. Proteins 1998, 32, 229-240.
39. Frare, D.; Polverino de Laureto, P.; Zurdo, J.; Dobson, C. M.; Fontana, A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 2004, 340, 1153-1165.
40. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, R.; Eisenberg, D. Structure of the cross-β spine of amyloid-like fibrils. Nature 2005, 435, 773-778.
41. Sutton, R. B.; Davletov, B. A.; Berghuis, A. M.; Sudhof, T. C.; Sprang, S. R. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell 1995, 80, 929-938.
42. Doyle, D. A.; Morais Cabral, J.; Pfuetzner, R. A.; Kuo, A.; Gulbis, J. M.; Cohen, S. L.; Chait, B. T.; MacKinnon, R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 1998, 280, 69-77.
43. Watson, J. D.; Milner-White E. J. A novel main-chain anion-binding site in proteins: The nest. A particular combination of phi,psi values in successive residues gives rise to anion-binding sites that occur commonly and are found often at functionally important regions. J. Mol. Biol. 2002, 315, 171-182.
44. Watson, J. D.; Milner-White E. J. The conformations of polypeptide chains where the main-chain parts of successive residues are enantiomeric. Their occurrence in cation and anion-binding regions of proteins. J. Mol. Biol. 2002, 315, 183-191.
45. Tycko, R. Solid-state NMR as a probe of amyloid fibril structure. Curr. Opin. Chem. Biol. 2000, 4, 500-506.
46. Nelson, R.; Eisenberg, D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 2006, 16, 1-6.
47. Cornilescu, G.; Delaglio, F.; Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 1999, 13, 289-302.
48. 13C′ chemical shifts in proteins using a density functional database. J. Biomol. NMR 2001, 21, 321-333.
49. Jaroniec, C. P.; MacPhee, C. E.; Astrof, N. S.; Dobson, C. M.; Griffin, R. G. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16748-16753.
50. Ross, E. D.; Edskes, H. K.; Terry, M. J.; Wickner, R. B. Primary sequence independence for prion formation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 12825-12830.
51. Caughey, B.; Raymond, G. J.; Bessen, R. A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 1998, 273, 32230-32235.
52. Telling, G. C.; Parchi, P.; DeArmond, S. J.; Cortelli, P.; Montagna, P.; Gabizon, R.; Mastrianni, J.; Lugaresi, E.; Gambetti, P.; Prusiner, S. B. Science 1996, 274, 2079-2082.
53. Wadsworth, J. D.; Hill, A. F.; Joiner, S.; Jackson, G. S.; Clarke, A. R.; Collinge, J. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell. Biol. 1999, 1, 55-59.
54. Jones, E. M.; Surewicz, W. K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 2005, 121, 63-72.
55. Lopez de la Paz, M.; Goldie, K.; Zurdo, J.; Lacroix, E.; Dobson, C. M.; Hoenger, A.; Serrano, L. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16052-16057.
56. Zurdo, J.; Guijarro, J. I.; Dobson, C. M. Preparation and characterization of purified amyloid fibrils. J. Am. Chem. Soc. 2001, 123, 8141-8142.
57. Zandomeneghi, G.; Krebs, M. R. H.; McCammon, M. G.; Fandrich, M. FTIR reveals structural differences between native β-sheet proteins and amyloid fibrils. Protein Sci. 2004, 13, 3314-3321.
58. Xu, S. H.; Bevis, B.; Arnsdorf, M. F. The assembly of amyloidogenic yeast Sup35 as assessed by scanning (atomic) force microscopy: An analogy to linear colloidal aggregation? Biophys. J. 2001, 81, 446-456.
59. Worchester, D. L. Structural origins of diamagnetic anisotropy in proteins. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 5475-5477.
60. Pauling, L. Diamagnetic anisotropy of the peptide group. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 2293-2294.
61. Fraser, P. E.; Duffy, L. K.; O'Mally, M. B.; Nguyen, J.; Inouye, H.; Kirschner, D. A. Morphology and antibody recognition of synthetic beta-amyloid peptides. J. Neurosci. Res. 1991, 28, 474-485.
62. Malinchik, S. B.; Inouye, H.; Szumowski, K. E.; Kirschner, D. A. Structural analysis of Alzheimer's beta (1-40) amyloid: Protofilament assembly of tubular fibrils. Biophys. J. 1998, 74, 537-545.
63. Huang T. H. J.; Yang D. S.; Fraser P. E.; Chakrabartty, A. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide - An in vitro model of preamyloid. J. Biol. Chem. 2000, 275, 36436-36440.
64. Chen, S.; Ferrone, F. A.; Wetzel, R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 11884-11889.
65. Gorman, P. M.; Yip, C. M.; Fraser, P. E.; Chakrabartty, A. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: A beta association kinetics atendosomal pH. J. Mol. Biol. 2003, 325, 743-757.
66. Kim, J. R.; Muresan, A.; Lee, K. Y. C.; Murphy, R. M. Urea modulation of beta-amyloid fibril growth: Experimental studies and kinetic models. Protein Sci. 2004, 13, 2888-2898.
67. Sunde, M.; Serpell, L. C.; Bartlam, M.; Fraser, P. E.; Pepys, M. B.; Blake, C. C. F. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 1997, 273, 729-739.
68. Nguyen, J. T.; Inouye, H.; Baldwin, M. A.; Fletterick, R. J.; Dohen, F. E.; Prusiner, S. B.; Kirschner, D. A. X-ray diffraction of scrapie prion rods and PrP peptides. J. Mol. Biol. 1995, 252, 412-422.
69. Wang, J.; Gülich, S.; Bradford, C.; Ramirez-Alvarado, M.; Regan, L. A Twisted four-sheeted model for an amyloid fibril. Structure 2006, 13, 1279-1288.
70. DeMarco, M. L.; Daggett, V. From conversion to aggregation: Protofibril formation of the prion protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2293-2298.
71. Lopez de la Paz, M.; Serrano, L. Sequence determinants of amyloid fibril formation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 87-92.
72. Thompson, M. J.; Sievers, S. A.; Karanicolas, J.; Ivanova, M. I.; Baker, D.; Eisenberg, D. The 3D profile method for identifying fibril-forming segments of proteins. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 4074-4078.